Solazyme Inc  

(Public, NASDAQ:SZYM)   Watch this stock  
Find more results for solazyme
11.14
+0.44 (4.11%)
May 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 10.60 - 11.49
52 week 6.45 - 14.34
Open 10.60
Vol / Avg. 668,352.00/662,321.00
Mkt cap 688.75M
P/E     -
Div/yield     -
EPS -1.52
Shares 61.83M
Beta     -
Inst. own 38%
Aug 5, 2013
Q2 2013 Solazyme Earnings Release Add to calendar
Jun 4, 2013
Solazyme Annual Shareholder Meeting - 2:30PM EDT - Add to calendar
May 30, 2013
Solazyme at Cowen Technology, Media & Telecom Conference - 8:45AM EDT - Add to calendar
May 8, 2013
Q1 2013 Solazyme Earnings Conference Call
May 6, 2013
Q1 2013 Solazyme Earnings Release
Mar 6, 2013
Solazyme at Raymond James Institutional Investors Conference
Feb 26, 2013
Solazyme at Morgan Stanley Technology, Media & Telecom Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin -397.08% -188.47%
Operating margin -349.70% -192.94%
EBITD margin - -184.96%
Return on average assets -39.82% -33.10%
Return on average equity -61.21% -39.23%
Employees 229 -
Carbon Disclosure Rating - -

Address

225 Gateway Blvd
SOUTH SAN FRANCISCO, CA 94080
United States - Map
+1-650-7804777 (Phone)
+1-650-9896700 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Solazyme, Inc. operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels. The Company also offers marine and microaquatic compounds for health and wellness products. Its products are used for biofuel production, replacements for fossil petroleum, and plant oils in various products ranging from green household cleaning supplies to cosmetics and foods. The Company serves renewable energy and industrial chemicals markets, as well as specialty ingredients markets in cosmetic, nutritional, and pharmaceutical products.

Officers and directors

Jerry L. Fiddler Independent Chairman of the Board
Age: 60
Bio & Compensation  - Reuters
Harrison F. Dillon Ph.D. President, Director
Age: 41
Bio & Compensation  - Reuters
Jonathan S. Wolfson JD, MBA Chief Executive Officer, Director
Age: 41
Bio & Compensation  - Reuters
Tyler W. Painter Chief Financial Officer
Age: 40
Bio & Compensation  - Reuters
Jean-Marc Rotsaert Chief Operating Officer
Age: 42
Bio & Compensation  - Reuters
Peter J. Licari Ph.D. Executive Vice President - Technology, Chief Technology Officer
Age: 48
Bio & Compensation  - Reuters
Paul T. Quinlan General Counsel, Corporate Secretary
Age: 49
Bio & Compensation  - Reuters
Peter Kovacs Director
Bio & Compensation  - Reuters
Michael V. Arbige Ph.D. Independent Director
Age: 57
Bio & Compensation  - Reuters
Ian T Clark Independent Director
Age: 51
Bio & Compensation  - Reuters